A new Danish study involving nearly 700,000 women showed that hormone replacement therapy might not put women at increased risk of heart disease, after all. In 2002, the Women's Health Initiative study ended because of an increased risk of breast cancer, blood clots, stroke and heart attack in women taking a combination of estrogen and progestin. Article